Prenetics Global Limited (PRE)
NASDAQ: PRE · Real-Time Price · USD
14.31
-0.50 (-3.38%)
Oct 9, 2025, 12:08 PM EDT - Market open
Company Description
Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally.
It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand.
The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into health, wellness, and genetic predispositions.
Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Prenetics Global Limited
| Country | Hong Kong |
| Founded | 2014 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 285 |
| CEO | Sheng Wu Yeung |
Contact Details
Address: Unit 703-706, K11 Atelier King’s Road, 728 King’s Road Quarry Bay Hong Kong | |
| Phone | 852 2210 9588 |
| Website | prenetics.com |
Stock Details
| Ticker Symbol | PRE |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001876431 |
| CUSIP Number | G72245106 |
| ISIN Number | KYG722451229 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Samantha Kwok | Chief of Staff to Group Chief Executive Officer and Vice President of People & Operations |
| Sheng Wu Yeung | Co-Founder, Chairperson and Chief Executive Officer |
| Dr. Chi Hung Tzang Ph.D. | Co-Founder and Chief Scientific Officer |
| Hoi Chun Lo | Chief Financial Officer |
| Dr. Senthil Kumar Sundaram M.D. | Chief Clinical Officer |
| Joel Neoh | Chief Consumer Officer |
| David Eric Vanderveen | Director and President of Americas |
| Dr. James DiNicolantonio | Chief Nutrition Officer, Member of Scientific and Medical Advisory Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 12, 2025 | 6-K | Report of foreign issuer |
| Sep 11, 2025 | EFFECT | Notice of Effectiveness |
| Sep 8, 2025 | F-3/A | Filing |
| Aug 22, 2025 | F-3/A | Filing |
| Aug 22, 2025 | 6-K | Report of foreign issuer |
| Aug 22, 2025 | 6-K/A | Filing |
| Aug 7, 2025 | 6-K/A | Filing |
| Aug 1, 2025 | 6-K | Report of foreign issuer |
| Jul 22, 2025 | F-3 | Filing |
| Jul 18, 2025 | 20-F/A | Filing |